These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. p53 gene mutations and p53 protein expression in human soft tissue sarcomas. Yoo J, Lee HK, Kang CS, Park WS, Lee JY, Shim SI. Arch Pathol Lab Med; 1997 Apr; 121(4):395-9. PubMed ID: 9140310 [Abstract] [Full Text] [Related]
3. p53 abnormalities in different subtypes of human sarcomas. Andreassen A, Oyjord T, Hovig E, Holm R, Flørenes VA, Nesland JM, Myklebost O, Høie J, Bruland OS, Børresen AL. Cancer Res; 1993 Feb 01; 53(3):468-71. PubMed ID: 8425179 [Abstract] [Full Text] [Related]
4. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas. Mousses S, McAuley L, Bell RS, Kandel R, Andrulis IL. Mod Pathol; 1996 Jan 01; 9(1):1-6. PubMed ID: 8821948 [Abstract] [Full Text] [Related]
6. Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas. Liu FS, Kohler MF, Marks JR, Bast RC, Boyd J, Berchuck A. Obstet Gynecol; 1994 Jan 01; 83(1):118-24. PubMed ID: 8272291 [Abstract] [Full Text] [Related]
7. p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas. Brachman DG, Hallahan DE, Beckett MA, Yandell DW, Weichselbaum RR. Cancer Res; 1991 Dec 01; 51(23 Pt 1):6393-6. PubMed ID: 1933904 [Abstract] [Full Text] [Related]
8. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Murakami Y, Hayashi K, Hirohashi S, Sekiya T. Cancer Res; 1991 Oct 15; 51(20):5520-5. PubMed ID: 1655254 [Abstract] [Full Text] [Related]
10. Frequent loss of expression or aberrant alternative splicing of P2XM, a p53-inducible gene, in soft-tissue tumours. Nawa G, Miyoshi Y, Yoshikawa H, Ochi T, Nakamura Y. Br J Cancer; 1999 Jun 15; 80(8):1185-9. PubMed ID: 10376970 [Abstract] [Full Text] [Related]
11. Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias. Corradini P, Inghirami G, Astolfi M, Ladetto M, Voena C, Ballerini P, Gu W, Nilsson K, Knowles DM, Boccadoro M. Leukemia; 1994 May 15; 8(5):758-67. PubMed ID: 8182933 [Abstract] [Full Text] [Related]
13. Abnormalities of p53 and p110RB tumor suppressor gene expression in human soft tissue tumors: correlations with cell proliferation and tumor grade. Wang J, Coltrera MD, Gown AM. Mod Pathol; 1995 Oct 15; 8(8):837-42. PubMed ID: 8552572 [Abstract] [Full Text] [Related]
15. Studies of the RB1 gene and the p53 gene in human osteosarcomas. Scholz RB, Kabisch H, Weber B, Röser K, Delling G, Winkler K. Pediatr Hematol Oncol; 1992 Sep 15; 9(2):125-37. PubMed ID: 1524989 [Abstract] [Full Text] [Related]
16. Mutation of the p53 gene in postradiation sarcoma. Nakanishi H, Tomita Y, Myoui A, Yoshikawa H, Sakai K, Kato Y, Ochi T, Aozasa K. Lab Invest; 1998 Jun 15; 78(6):727-33. PubMed ID: 9645763 [Abstract] [Full Text] [Related]
17. p53 expression, mutation, and allelic deletion in ovarian cancer. McManus DT, Yap EP, Maxwell P, Russell SE, Toner PG, McGee JO. J Pathol; 1994 Nov 15; 174(3):159-68. PubMed ID: 7823248 [Abstract] [Full Text] [Related]
18. Genetic alterations of the p53 gene are a feature of malignant mesotheliomas. Cote RJ, Jhanwar SC, Novick S, Pellicer A. Cancer Res; 1991 Oct 01; 51(19):5410-6. PubMed ID: 1913660 [Abstract] [Full Text] [Related]
19. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. Huang Y, Meltzer SJ, Yin J, Tong Y, Chang EH, Srivastava S, McDaniel T, Boynton RF, Zou ZQ. Cancer Res; 1993 Apr 15; 53(8):1889-94. PubMed ID: 8467510 [Abstract] [Full Text] [Related]
20. H-ras and K-ras mutations in soft tissue sarcoma: comparative studies of sarcomas from Korean and American patients. Yoo J, Robinson RA. Cancer; 1999 Jul 01; 86(1):58-63. PubMed ID: 10391564 [Abstract] [Full Text] [Related] Page: [Next] [New Search]